Copyright
©The Author(s) 2024.
World J Diabetes. Mar 15, 2024; 15(3): 463-474
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.463
Published online Mar 15, 2024. doi: 10.4239/wjd.v15.i3.463
Figure 3 Boxplots showing latest weight, with dapagliflozin, canagliflozin, and empagliflozin in male and female patients.
SGLT2: Sodium glucose cotransporter 2; F: Female; M: Male.
- Citation: Islam L, Jose D, Alkhalifah M, Blaibel D, Chandrabalan V, Pappachan JM. Comparative efficacy of sodium glucose cotransporter-2 inhibitors in the management of type 2 diabetes mellitus: A real-world experience. World J Diabetes 2024; 15(3): 463-474
- URL: https://www.wjgnet.com/1948-9358/full/v15/i3/463.htm
- DOI: https://dx.doi.org/10.4239/wjd.v15.i3.463